RFK Jr.’s HHS is letting pharmacies sell 6 unproven peptides like the ‘Wolverine stack’ — and no regulator will check what’s in them

Résumé détaillé

In July 2026 the committee voted 8-6 to expand access to six peptides: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500.

Unregulated peptides for weight loss, muscle building, longevity and more are a roaring wellness fad – even though these substances have not been proved safe and effective and have not been approved by the U.S. Food and Drug Administration.

Until now, consumers were getting wellness peptides online through the so-called gray market, where companies rely on legal loopholes to sell them. Due to a push from Health and Human Services Secretary Robert F. Kennedy Jr., a vocal proponent of using peptides, an HHS policy on Oct. 29, 2026, will expand access to six peptides by allowing specialized pharmacies to make and sell them.

I am a health law professor who researches and teaches FDA law and policy. Consumers of peptides will soon have more options, but they should also be aware of the risks.

Peptides are short chains of amino acids, which are building blocks for proteins. More than 7,000 peptides occur naturally in the human body. Some peptides – both natural and synthetic – have been developed as medicines, such as insulin and GLP-1 drugs, including Ozempic and Wegovy.

Peptides that are commercialized as pharmaceutical drugs go through clinical trials and are approved by the FDA. But the slew of “wellness” peptides promoted by influencers and sold online or at wellness stores are not evaluated by any regulator.

American consumers have been able to buy wellness peptides online for over a decade. Until 2023 some of these peptides were sold at some specialized pharmacies as well. But that year the FDA restricted access to several wellness peptides due to unnamed “significant safety concerns,” forbidding specialized pharmacies from making and selling them. This did not prevent consumers from buying peptides online and at stores, however.

Since the early 2020s, the mainstreaming of wellness through the MAHA movement has driven up consumer interest in peptides.

Earlier this year, Kennedy pushed the FDA to review several peptides that the agency had restricted in 2023.

The vote came…

Début de l'article, extrait de Fortune. Pour lire la suite, ouvrez l'article chez le média.